It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 | Hyderabad, Telangana, India | ActiveMuppandal Genomics And Immunologicals Private Limited, a active private limited company, was established on 03 July 2017 in Hyderabad, Telangana, India. Engaging in science research within the research & development sector, it holds CIN: U73100TG2017PTC118062. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jeyalekshmi Thanumalayan (Director), Kathirvel (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No: 417, Sai Durga Gardens Nacharam, Hyderabad, Telangana, 500076.
U73100TG2017PTC118062
118062
03 July 2017
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Muppandal Genomics And Immunologicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jeyalekshmi Thanumalayan | Director | 03 Jul 2017 | Current |
| Kathirvel | Director | 03 Jul 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Muppandal Genomics And Immunologicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 108.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2457.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Muppandal Genomics And Immunologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Muppandal Genomics And Immunologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Muppandal Genomics And Immunologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Muppandal Genomics And Immunologicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Muppandal Genomics And Immunologicals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Muppandal Genomics And Immunologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity Jeyalekshmi Thanumalayan was appointed as a Director was appointed as a Director on 03 Jul 2017 & has been associated with this company since 8 years 5 months . was completed.
Progress on Kathirvel was appointed as a Director was appointed as a Director on 03 Jul 2017 & has been associated with this company since 8 years 5 months . was documented.
The activity Muppandal Genomics And Immunologicals Private Limited was registered on 03 Jul 2017 with Roc Hyderabad & aged 8 years 5 months as per MCA records. was completed.
The CIN of Muppandal Genomics And Immunologicals Private Limited is U73100TG2017PTC118062.
Muppandal Genomics And Immunologicals Private Limited is headquartered at Flat No: 417, Sai Durga Gardens Nacharam, Hyderabad, Telangana, 500076.
Muppandal Genomics And Immunologicals Private Limited was incorporated on 03 July 2017.
The current directors of Muppandal Genomics And Immunologicals Private Limited are
The primary industry of Muppandal Genomics And Immunologicals Private Limited is Research & Development.
Muppandal Genomics And Immunologicals Private Limited is unlisted.
The authorized capital of Muppandal Genomics And Immunologicals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Muppandal Genomics And Immunologicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX